Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-23-024217
Filing Date
2023-05-25
Accepted
2023-05-25 16:07:01
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 may_2023_rdo.htm 424B5 548215
2 GRAPHIC img182096599_0.jpg GRAPHIC 8553
3 GRAPHIC img182096599_1.jpg GRAPHIC 5497
4 GRAPHIC img182096599_2.jpg GRAPHIC 5497
  Complete submission text file 0000950170-23-024217.txt   576790
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-261811 | Film No.: 23960469
SIC: 2835 In Vitro & In Vivo Diagnostic Substances